We’re very excited to announce that the Gwendolyn Strong Foundation (GSF), a partner of FightSMA that is led by FightSMA board member Bill Strong, is starting a very exciting project to grant 50 iPads in 50 days! The effort is called Project Mariposa. Here’s some information from the GSF website:
Project Mariposa will initially focus on granting iPads to those impacted by Spinal Muscular Atrophy (SMA) — 50 iPads in 50 weeks. These incredible devices, coupled with the growing application library that accompanies them, are literally life-changing in assisting with communication, education, and independence. The iPad is opening up new avenues that were previously impossible. It’s large screen size, light weight, portability, and featherlight touch screen make access to education, entertainment, and independence possible and in some cases it is allowing children to communicate for the first time in their lives. Project Mariposa’s goal is to provide that life-changing positivity for a large number of people.
Applications are now being accepted. The first grant recipient will be announced on Friday, February 3, 2012. One grant recipient will be announced each week via theGSF Facebook Fan Page. To submit your application, click here!





“SMA is a devastating disease that leads to the loss of motor neurons resulting in muscle weakness and respiratory failure in children. The genetic cause of this disease is well understood, but there are currently no effective disease-modifying therapies. Currently, treatment of SMA is entirely symptomatic and focuses on preserving muscle strength and lung function by physical therapy and assisted ventilation. This supportive approach has improved the natural history of SMA by extending life expectancy, but muscle weakness and atrophy are not affected. A disease-modifying drug like ISIS-SMNRx that specifically targets the cause of the disease could, for the first time, restore muscle strength and respiratory function and dramatically improve the children’s function and quality of life,” said Darryl C. De Vivo, M.D, Sidney Carter Professor of Neurology and Pediatrics and Co-Director of the Motor Neuron Center at Columbia University Medical Center.
